Epipen maker to pay $465M

The embattled pharmaceutical company said Friday it has agreed to a settlement with the Department of Justice and several other agencies. Mylan was accused of falsely classifying Epipen, a life-saving allergic reaction treatment, in order to overcharge Medicaid for them.